<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Document</title>
    <link rel="stylesheet" href="css/style.css">
    <link rel="stylesheet" href="css/reset.css">
    <link href="https://fonts.hlxcdn.com/fonts/fonts.css" rel="stylesheet">
    <link  href="https://cdnjs.cloudflare.com/ajax/libs/fotorama/4.6.4/fotorama.css" rel="stylesheet">
</head>
<body>
    <header class="header">
        <div class ="header__cap">
            <div class="container header__cap-container">
                <p class ="header__cap-name">We’ve updated our policies. <a href="#" class="header__cap-name header__cap-name--link">Learn more</a></p>
            </div>
        </div>
        <div class="container header__container">
            <div class="header__logo-background">
                <img class="header__logo-tittle" src="./img/logo.png" alt="">
            </div> 
            <nav class="header__nav">
                <ul class="header__list">
                    <li class="header__click"><a href="#" class="header__link">Population Health</a></li>
                    <li class="header__click"><a href="#" class="header__link">DNA Test</a></li>
                    <li class="header__click"><a href="#" class="header__link">Register Kid</a></li>
                    <li class="header__click"><a href="#" class="header__link">Sign In</a></li>
                    <li class="header__click"><a href="#" class="header__link"><img src="./img/cart-icon.svg" alt=""></a></li>
                </ul>
            </nav>
            <nav class="header__mobile">
                <ul class="header__mobile-list">
                    <li class="header__mobile-link "> <img class="header__mobile-tittle" src="./img/icons8-меню.svg" alt="">
                        <ul class="header__mobile-downlist">
                            <li class="header__click"><a href="#" class="header__link">Population Health</a></li>
                            <li class="header__click"><a href="#" class="header__link">DNA Test</a></li>
                            <li class="header__click"><a href="#" class="header__link">Register Kid</a></li>
                            <li class="header__click"><a href="#" class="header__link">Sign In</a></li>
                        </ul>
                    </li>
                </ul>
            </nav>
        </div>
    </header>
    <section class="exome">
        <div class="container exome__container">
            <div class="exome__content">
                <h1 class="exome__tittle">The Exome+® assay</h1>
                <p class="exome__description">Get the performance of a targeted panel, the breadth of a microarray, and the completeness 
                    of an exome — all from one assay.</p>
            </div>
        </div>
    </section>
    <section class="evoidCompromise">
        <div class="container evoidCompromise__container">
            <div class="evoidCompromise__content">
                <h2 class="evoidCompromise__tittle">Avoid compromise </h2>
                <p class="evoidCompromise__description">Through custom development work and proprietary bioinformatics solutions, we’ve created an assay that meets the needs of both clinicians and researchers in contrast to off-the-shelf assays that are typically optimized for one or the <br><br>
                Read on to learn how we’ve eliminated the compromises clinicians and researchers typically have to make on cost, quality, and breadth when choosing an assay.</p>
            </div>
            <div class="evoidCompromise__wrapper">
                <div class="evoidCompromise__upper" >
                    <div class="evoidCompromise__wrapper--circle ">
                        <div class="evoidCompromise__wrapper--circle-description">Whole Exome Sequencing</div>
                    </div>
                </div>
                <div class="evoidCompromise__bottom">
                    <div class="evoidCompromise__wrapper--circle evoidCompromise__wrapper--circle-left">
                        <div class="evoidCompromise__wrapper--circle-description">Microarray and IcWgs</div>
                    </div>
                    <div class="evoidCompromise__wrapper--circle evoidCompromise__wrapper--circle-right">
                        <div class="evoidCompromise__wrapper--circle-description">Targeted Panels</div>
                    </div>
                </div>
            </div>
        </div>
    </section>
    <section class="wrapper">
        <div class="container wrapper__container">
            <div class="wrapper__content">
                <h3 class="wrapper__tittle">An Exome, plus more</h3>
                <p class="wrapper__description">  A panel-grade, clinical exome plus ~300,000 informative non-coding regions (and tens of millions of imputed variants) full mitochondrial genome.</p>
            </div>
            <div class="wrapper__content">
                <h3 class="wrapper__tittle">Panel-grade</h3>
                <p class="wrapper__description">  A ≥ 99.5% call rate across ~ 600 genes that are important in the areas of hereditary cancer, cardiovascular disease, pharmacogenomics, and carrier screening.</p>
            </div>
            <div class="wrapper__content">
                <h3 class="wrapper__tittle">Comprehensive</h3>
                <p class="wrapper__description"> Covers ~20,000 genes and detects and reports SNPs, indels, multinucleotide variants, substitutions, and complex variants, intragenic copy number variants (CNVs), and multigenic CNVs.</p>
            </div>
        </div>
    </section>
    <section class="perfomence">
        <div class="container perfomence__container">
            <h2 class="perfomence__tittle">Key performance metrics</h2>
                <div class="slider fotorama  test ">
                    <table  class="perfomence__table">
                        <tr>
                            <td class="perfomence__table--tittle perfomence__table--first">Tier</td>
                            <td class="perfomence__table--tittle perfomence__table--second">Regions</td>
                            <td class="perfomence__table--tittle perfomence__table--third">Mean SNP</td>
                            <td class="perfomence__table--tittle perfomence__table--fours">Mean SNV</td>
                        </tr>
                        <tr>
                            <td class="perfomence__table--tier1 perfomence__table--styleText">Tier1</td>
                            <td class="perfomence__table--tier1 perfomence__table--styleText">~600 genes important in the areas of hereditary cancer, cardiovascular disease, pharmacogenomics, and carrier screening
                                <ul class="perfomence__table--list">
                                    <li class="perfomence__table--list">Includes 59 medically actionable genes</li>
                                    <li class="perfomence__table--list">Includes CDC Tier 1 genes</li>
                                </ul>
                                
                            </td>
                            <td class="perfomence__table--tier1 perfomence__table--styleText">≥99.5%</td>
                            <td class="perfomence__table--tier1 perfomence__table--styleText">≥99.7%</td>
                        </tr>
                        <tr>
                            <td class="perfomence__table--tier2 perfomence__table--styleText">Tier2</td>
                            <td class="perfomence__table--tier2 perfomence__table--styleText">~3,000 genes related to single-gene disorders
                            </td>
                            <td class="perfomence__table--tier2 perfomence__table--styleText">≥98%</td>
                            <td class="perfomence__table--tier2 perfomence__table--styleText">≥99.6%</td>
                        </tr>
                        <tr>
                            <td class="perfomence__table--tier3 perfomence__table--styleText">Tier3</td>
                            <td class="perfomence__table--tier3 perfomence__table--styleText">Whole exome</td>
                            <td class="perfomence__table--tier3 perfomence__table--styleText">≥96%</td>
                            <td class="perfomence__table--tier3 perfomence__table--styleText">≥99.57%</td>
                        </tr>
                        </table>
                    <table  class="perfomence__table">
                        <tr>
                            <td class="perfomence__table--tittle perfomence__table--first">Tier</td>
                            <td class="perfomence__table--tittle perfomence__table--second">Regions</td>
                            <td class="perfomence__table--tittle perfomence__table--third">Mean SNP</td>
                            <td class="perfomence__table--tittle perfomence__table--fours">Mean SNV</td>
                        </tr>
                        <tr>
                            <td class="perfomence__table--tier1 perfomence__table--styleText">Tier1</td>
                            <td class="perfomence__table--tier1 perfomence__table--styleText">~600 genes important in the areas of hereditary cancer, cardiovascular disease, pharmacogenomics, and carrier screening
                                 <ul class="perfomence__table--list">
                                    <li class="perfomence__table--list">Includes 59 medically actionable genes</li>
                                    <li class="perfomence__table--list">Includes CDC Tier 1 genes</li>
                                </ul>   
                            </td>
                            <td class="perfomence__table--tier1 perfomence__table--styleText">≥99.5%</td>
                            <td class="perfomence__table--tier1 perfomence__table--styleText">≥99.7%</td>
                        </tr>
                        <tr>
                            <td class="perfomence__table--tier2 perfomence__table--styleText">Tier2</td>
                            <td class="perfomence__table--tier2 perfomence__table--styleText">~3,000 genes related to single-gene disorders
                            </td>
                            <td class="perfomence__table--tier2 perfomence__table--styleText">≥98%</td>
                            <td class="perfomence__table--tier2 perfomence__table--styleText">≥99.6%</td>
                        </tr>
                        <tr>
                            <td class="perfomence__table--tier3 perfomence__table--styleText">Tier3</td>
                            <td class="perfomence__table--tier3 perfomence__table--styleText">Whole exome</td>
                            <td class="perfomence__table--tier3 perfomence__table--styleText">≥96%</td>
                            <td class="perfomence__table--tier3 perfomence__table--styleText">≥99.57%</td>
                        </tr>
                    </table> 
                </div>
        </div> 
    </section>
    <section class="benefits">
        <div class="container benefits__container ">
            <div class="benefits__cap">
                <h2 class="benefits__tittle">Bringing the benefits of multiple assays into one</h2>
                <p class="benefits__description">Helix’s Exome+® assay has been carefully optimized to provide the benefits of lcWGS, whole exome sequencing, microarrays, and targeted panels — all in one assay.</p>
            </div>
            <ul class="benefits__list">
                <li data-tab="1"  class="benefits__link is-active">Panels</li>
                <li data-tab="2"  class="benefits__link">Whole Exome Sequencing</li>
                <li data-tab="3"  class="benefits__link">lcWGS and Microarrays</li>
            </ul>
            <div class="benefits__desctop">
                <div data-tab-content="1" class="benefits__content benefits__content--desctop is-active">
                    <div class="benefits__info">
                        <h3 class="benefits__info--tittle">Targeted Panels</h3>
                        <p class="benefits__info--description">Panels are often used in clinical settings because they’re low cost and provide high quality coverage 
                            of specific, pre-defined genomic regions of interest. While useful in certain settings, such assays are limited by their narrow focus.<br><br>
                            With ≥ 99.5% call rate across ~600 genes relevant 
                            to many disease states, the Exome+ assay enables you to run multiple panel-grade analyses with a single sample.</p>
                    </div>
                    <div class="benefits__exome">
                        <img class="benefits__exome--pain" src="./img/Oval.png" alt="">
                    </div>
                </div>
                <div data-tab-content="2" class="benefits__content benefits__content--desctop">
                    <div class="benefits__info">
                        <h3 class="benefits__info--tittle">Whole Exome Sequencing</h3>
                        <p class="benefits__info--description">Panels are often used in clinical settings because they’re low cost and provide high quality coverage 
                            of specific, pre-defined genomic regions of interest. While useful in certain settings, such assays are limited by their narrow focus.<br><br>
                            With ≥ 99.5% call rate across ~600 genes relevant 
                            to many disease states, the Exome+ assay enables you to run multiple panel-grade analyses with a single sample.</p>
                    </div>
                    <div class="benefits__exome">
                        <img class="benefits__exome--pain" src="./img/Oval2.png" alt="">
                    </div>
                </div>
                <div data-tab-content="3" class="benefits__content benefits__content--desctop">
                    <div class="benefits__info">
                        <h3 class="benefits__info--tittle">lcWGS and Microarrays</h3>
                        <p class="benefits__info--description">Panels are often used in clinical settings because they’re low cost and provide high quality coverage 
                            of specific, pre-defined genomic regions of interest. While useful in certain settings, such assays are limited by their narrow focus.<br><br>
                            With ≥ 99.5% call rate across ~600 genes relevant 
                            to many disease states, the Exome+ assay enables you to run multiple panel-grade analyses with a single sample.</p>
                    </div>
                    <div class="benefits__exome">
                        <img class="benefits__exome--pain" src="./img/Oval3.png" alt="">
                    </div>
                </div>
            </div>         
            <div class="benefits__mobile">
                <div class="slider-benefits fotorama  test ">
                    <div class="benefits__content ">
                        <div class="benefits__info">
                            <h3 class="benefits__info--tittle">Targeted Panels</h3>
                            <p class="benefits__info--description">Panels are often used in clinical settings because they’re low cost and provide high quality coverage 
                                of specific, pre-defined genomic regions of interest. While useful in certain settings, such assays are limited by their narrow focus.<br><br>
                                With ≥ 99.5% call rate across ~600 genes relevant 
                                to many disease states, the Exome+ assay enables you to run multiple panel-grade analyses with a single sample.</p>
                        </div>
                        <div class="benefits__exome">
                            <img class="benefits__exome--pain" src="./img/Oval.png" alt="">
                        </div>
                    </div>
                    <div class="benefits__content ">
                        <div class="benefits__info">
                            <h3 class="benefits__info--tittle">Whole Exome Sequencing</h3>
                            <p class="benefits__info--description">Panels are often used in clinical settings because they’re low cost and provide high quality coverage 
                                of specific, pre-defined genomic regions of interest. While useful in certain settings, such assays are limited by their narrow focus.<br><br>
                                With ≥ 99.5% call rate across ~600 genes relevant 
                                to many disease states, the Exome+ assay enables you to run multiple panel-grade analyses with a single sample.</p>
                        </div>
                        <div class="benefits__exome">
                            <img class="benefits__exome--pain" src="./img/Oval2.png" alt="">
                        </div>
                    </div>
                    <div class="benefits__content ">
                        <div class="benefits__info">
                            <h3 class="benefits__info--tittle">lcWGS and Microarrays</h3>
                            <p class="benefits__info--description">Panels are often used in clinical settings because they’re low cost and provide high quality coverage 
                                of specific, pre-defined genomic regions of interest. While useful in certain settings, such assays are limited by their narrow focus.<br><br>
                                With ≥ 99.5% call rate across ~600 genes relevant 
                                to many disease states, the Exome+ assay enables you to run multiple panel-grade analyses with a single sample.</p>
                        </div>
                        <div class="benefits__exome">
                            <img class="benefits__exome--pain" src="./img/Oval3.png" alt="">
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>
    <section class="profeed">
        <div class="container profeed__container">
            <h2 class="profeed__tittle">A future proofed assay</h2>
            <p class="profeed__description">There are several advantages to running panels in the presence of a whole exome, including flexible test design, flexible re-testing, and increased functionality.</p>
            <div class="profeed-wrapper__content">
                <div class="profeed-wrapper-open">
                    <h3 data-profeed-link="1" class="profeed-wrapper-open__tittle is-active">Flexible test design</h3>
                    <div data-profeed-text="1" class="profeed-wrapper-open__description is-active">
                        <p  class="profeed-wrapper-open__description--text ">     
                            The Exome+ assay provides the flexibility needed to build a comprehensive panel that can be expanded over time. With ~20,000 genes sequenced in each sample, every gene becomes a candidate for inclusion. And, while we have ensured the highest call rates across those genes that are most likely to belong to a panel, the Exome+ assay delivers high call rates for all genes beyond this core set.    
                        </p>
                        <div class="profeed-wrapper-open__img1"> <img src="./img/1.png" alt="" class="profeed-wrapper-open__img"></div>
                    </div>
                    <h3 data-profeed-link="2" class="profeed-wrapper-open__tittle">Flexible test design</h3>
                    <div data-profeed-text="2" class="profeed-wrapper-open__description">
                        <p class="profeed-wrapper-open__description--text">     
                            The Exome+ assay provides the flexibility needed to build a comprehensive panel that can be expanded over time. With ~20,000 genes sequenced in each sample, every gene becomes a candidate for inclusion. And, while we have ensured the highest call rates across those genes that are most likely to belong to a panel, the Exome+ assay delivers high call rates for all genes beyond this core set.    
                        </p>
                        <div class="profeed-wrapper-open__img1"> <img src="./img/1.png" alt="" class="profeed-wrapper-open__img"></div>
                    </div>
                    <h3 data-profeed-link="3" class="profeed-wrapper-open__tittle">Flexible test design</h3>
                    <div data-profeed-text="3" class="profeed-wrapper-open__description">
                        <p  class="profeed-wrapper-open__description--text ">     
                            The Exome+ assay provides the flexibility needed to build a comprehensive panel that can be expanded over time. With ~20,000 genes sequenced in each sample, every gene becomes a candidate for inclusion. And, while we have ensured the highest call rates across those genes that are most likely to belong to a panel, the Exome+ assay delivers high call rates for all genes beyond this core set.    
                        </p>
                        <div class="profeed-wrapper-open__img1"> <img src="./img/1.png" alt="" class="profeed-wrapper-open__img"></div>
                    </div>
                </div>
            </div>
        </div>
        
    </section>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.1/jquery.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/fotorama/4.6.4/fotorama.js"></script>
    <script src="./js/script.js"></script>
</body>
</html>